Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART

Bulletin of Mathematical Biology

Volumn 67, Issue 6, 2005, Pages 1227-1251

  Jones, Laura E ^a   Perelson, Alan S ^b  

^a Department of Obstetrics Gynecology   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIDS RELATED COMPLEX; ARTICLE; BIOLOGICAL MODEL; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPUTER SIMULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; VIREMIA; VIROLOGY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COMPUTER SIMULATION; HIV INFECTIONS; HIV-1; HUMANS; MODELS, IMMUNOLOGICAL; VIREMIA;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 24944439857     PISSN: 00928240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bulm.2005.01.006     Document Type: Article

References (50)

1. V.P. Badovinac, B.B. Porter, and J.T. Harty Programmed contraction of CD8+ T cells after infection Nature Immunol. 3 2002 619 626
2. M.J. Bevan Helping the CD8+ T-cell response Nature Rev. Immunol. 4 2004 595 602
3. J.N. Blattman, R. Antia, D.J.D. Sourdive, X. Wang, S.M. Kaech, K. Murali-Krishna, J.D. Altman, and R. Ahmed Estimating the precursor frequency of naive antigen-specific CD8 T cells J. Exp. Med. 195 2002 657 664
4. S. Bonhoeffer, J.M. Coffin, and M.A. Nowak Human immunodeficiency virus drug therapy and virus load J. Virol. 71 1997 3275 3278
5. B. Brichacek, S. Swindells, E.N. Janoff, S. Pirruccelo, and M. Stevenson Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumoccocal vaccine J. Infect. Dis. 174 1996 1191 1199
6. D.S. Callaway, and A.S. Perelson HIV-1 infection and low steady state viral loads Bull. Math. Biol. 64 2002 29 64
7. M.P. Davenport, R.M. Ribeiro, and A.S. Perelson Kinetics of virus specific CD8+ T cells and the control of HIV infection J. Virol. 78 2004 10096 10103
8. R.J. De Boer, M. Oprea, R. Antia, K. Murali-Krishna, R. Ahmed, and A.S. Perelson Recruitment times, proliferation, and apoptosis rates during the CD8+ T cell response to LCMV J. Virol. 75 2001 10663 10669
9. R.J. De Boer, D. Homann, and A.S. Perelson Different dynamics of CD4+ and CD8+ T cell responses during and after acute lymphocytic choriomeningitis virus infection J. Immunol. 171 2003 3928 3935
10. De Boer, R.J., Perelson, A.S. Estimating division and death rates from CFSE data. J. Comput. Appl. Math. (in press)
11. E.K. Deenick, A.V. Gett, and P.D. Hodgkin Stochastic model of T cell proliferation: A calculus revealing IL-2 regulation of precursor frequencies, cell cycle time, and survival J. Immunol. 170 2003 4963 4972
12. M. Di Mascio, M. Markowitz, M. Louie, C. Hogan, A. Hurley, D.D. Ho, and A.S. Perelson Viral blip dynamics during highly active antiretroviral therapy J. Virol. 77 2003 12165 12172
13. M. Di Mascio, G. Dornadula, H. Zhang, J. Sullivan, Y. Xu, J. Kulkosky, R. Pomerantz, and A.S. Perelson In a subset of patients on highly active antiretroviral therapy plasma HIV-1 RNA can decay from 50 copies/ml to <5 copies/ml with a half-life of six months J. Virol. 77 2003 2271 2275
14. M. Di Mascio, R.M. Ribeiro, M. Markowitz, D.D. Ho, and A.S. Perelson Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapy Math. Biosci. 188 2004 47 62
15. M. Di Mascio, M. Markowitz, M. Louie, A. Hurley, C. Hogan, V. Simon, D. Follman, D.D. Ho, and A.S. Perelson Dynamics of intermittent viremia during highly active antiretroviral therapy in patients who initiate therapy during chronic versus acute and early human immunodeficiency virus type 1 infection J. Virol. 78 2004 10566 10573
16. R.M. Donovan, C.E. Bush, N.P. Markowitz, D.M. Baxa, and L.D. Saravolatz Changes in virus load markers during AIDS-associated opportunistic diseases in human-immunodeficiency virus-infected persons J. Infect. Dis. 174 1996 401 403
17. G. Dornadula, H. Zhang, B. VanUitert, J. Stern, L. Livornese Jr., M.J. Ingerman, J. Witek, R.J. Kedanis, J. Natkin, J. DeSimone, and R.J. Pomerantz Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy J. Amer. Med. Assoc. 282 1999 1627 1632
18. N.M. Ferguson, F. deWolf, A.C. Ghani, C. Fraser, C.A. Donnelly, P. Reiss, J.M.A. Lange, S.A. Danner, G.P. Garnett, J. Goudsmit, and R.M. Anderson Antigen-driven CD4+ T-cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy Proc. Natl. Acad. Sci. USA 96 1999 15167 15172
19. C. Fraser, N.M. Ferguson, F. de Wolf, and R.M. Anderson The role of antigenic stimulation and cytotoxic T cell activity in regulating long-term immunopathogenesis of HIV: mechanisms and clinical implications Proc. R. Soc. Lond. B. 268 2001 2085 2095
20. C. Fraser, N.M. Ferguson, and R.M. Anderson Quantification of intrinsic residual viral replication in treated HIV-infected patients Proc. Natl. Acad. Sci. USA 98 2001 15167 15172
21. A.V. Gett, and P.D. Hodgkin A cellular calculus for signal integration by T cells Nature Immunol. 1 2000 239 244
22. Holte, S.A., Melvin, A., Mullins, J., Frenkel, L., 2001. Density-dependent decay in HIV dynamics after HAART (Abstract 394). In: 8th Conference on Retroviruses and Opportunistic Infections. Foundation for Retrovirology and Human Health, Alexandria, VA, USA
23. L.E. Jones, and A.S. Perelson Modeling the effects of vaccination on chronically infected HIV-positive patients JAIDS 31 2002 369 377
24. S.M. Kaech, and R. Ahmed Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells Nature Immunol. 2 2001 415 422
25. D.E. Kaufmann, P.M. Bailey, J. Sidney, B. Wagner, P.J. Norris, M.N. Johnston, L.A. Cosimi, M.M. Addo, M. Lichterfeld, M. Altfeld, N. Frahm, C. Brander, A. Sette, B.D. Walker, and E.S. Rosenberg Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides J. Virol. 78 2004 4463 4477
26. R.B. Kim, M.F. Fromm, C. Wandel, B. Leake, A.J. Wood, D.M. Roden, and G.R. Wilkinson The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors J. Clin. Invest. 101 1998 289 294
27. W.T. Lee, G. Pasos, L. Cecchini, and J.N. Mittler Continued antigen stimulation is not required during CD4+ T cell clonal expansion J. Immunol. 168 2002 1682 1689
28. A.R. McLean, and M.A. Nowak Models of interactions between HIV and other pathogens J. Theor. Biol. 155 1992 69 102
29. E.R. Meaden, P.G. Hoggard, P. Newton, J.F. Tjia, D. Aldam, D. Cornforth, J. Lloyd, I. Williams, D.J. Back, and S.H. Khoo P-glycoprotein and MRP1 expression and reduced ritonavir and saquinavir accumulation in HIV-infected individuals J. Antimicrob. Chemother. 50 2002 583 588
30. H. Mohri, S. Bonhoeffer, S. Monard, A.S. Perelson, and D.D. Ho Rapid turnover of T-lymphocytes in SIV-infected rhesus macaques Science 279 1998 1223 1227
31. K. Murali-Krishna, J.D. Altman, M. Suresh, D. Sourdive, A. Zajac, J.D. Miller, J. Slansky, and R. Ahmed Counting antigen-specific CD8 T cells: a reevaluation of the bystander activation during viral infection Immunity 8 1998 177 187
32. K. Murali-Krishna, J.D. Altman, M. Suresh, D. Sourdive, A. Zajac, and R. Ahmed In vivo dynamics of antiviral CD8+ T cell responses to different epitopes: an evaluation of bystander activation in primary and secondary responses to viral infection Adv. Exp. Med. Biol. 452 1998 123 142
33. M.A. Nowak, and C.R.M. Bangham Population dynamics of immune responses to persistent viruses Science 272 1996 74 79
34. M.A. Nowak, and R.M. May Virus dynamics: Mathematical Principles of Immunology and Virology 2000 Oxford University Press Oxford
35. W.A. O'Brien, K. Grovit-Ferbas, A. Namazi, S. Ovcak-Derzic, H.J. Wang, J. Park, C. Yeramian, S.H. Mao, and J.A. Zack Human immunodeficiency virus type 1 replication can be increased in the peripheral blood of seropositive patients after influenza vaccination Blood 86 1995 1982-1089
36. A.S. Perelson, A.U. Neumann, M. Markowitz, J.M. Leonard, and D.D. Ho HIV-1 dynamics in vivo: Virion clearance rate, infected cell lifespan, and viral generation time Science 271 1996 1582 1586
37. A.S. Perelson, P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowitz, and D.D. Ho Decay characteristics of HIV-1 infected compartments during combination therapy Nature 271 1997 1582 1586
38. A.S. Perelson Modelling viral and immune system dynamics Nature Rev. Immunol. 2 2002 28 36
39. C. Perno, F.M. Newcombe, D. Davis, S. Aquaro, R.W. Humphrey, R. Calio, and R. Yarchoan Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus J. Infect. Dis. 178 1998 413 422
40. P. Puddu, S. Fais, F. Luciani, G. Gherardi, M.L. Dupuis, G. Romagnioli, C. Ramoni, M. Cianfriglia, and S. Gessani Interferon- γ up-regulates expression and activity of P-glycoprotein in human peripheral blood monocyte-derived macrophages Lab. Invest. 79 1999 1299 1309
41. P. Revy, M. Sospedra, B. Barbour, and A. Trautman Functional antigen-independent synapses formed between T-cells and dendritic cells Nature Immunol. 2 2001 925 931
42. N. Sachsenberg, A.S. Perelson, S. Yerly, G.A. Schockmel, D. Leduc, B. Hirschel, and L. Perrin Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen J. Exp. Med. 187 1998 1295 1303
43. S.K. Stanley, M.A. Ostrowski, J.S. Justement, K. Gantt, S. Hedayati, M. Mannix, K. Roche, D. Schwartzentruber, C.H. Fox, and A.S. Fauci Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1 N. Engl. J. Med. 334 1996 1222 1230
44. S.I. Staprans, B. Hamilton, S. Follansbee, T. Elbeik, P. Barbosa, R. Grant, and M. Feinberg Activation of virus replication after vaccination of HIV-1 infected individuals J. Exp. Med. 182 1995 1727 1737
45. J.C. Sun, M.A. Williams, and M.J. Bevan CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection Nature Immunol. 5 2004 927 933
46. M.J. Van Stipdonk, E.E. Lemmons, and S.P. Schoenberger Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation Nature Immunol. 21 2001 29 70
47. D. Wodarz, and M.A. Nowak CD8 escape, immunodominance, and antigenic escape Eur. J. Immunol. 30 2000 2704 2712
48. D. Wodarz, R.M. May, and M.A. Nowak The role of antigen-independent persistence of memory cytotoxic T lymphocytes Int. Immunol. 12 2000 467 477
49. P. Wong, and E.G. Pamer CD8 T-cell responses to infectious pathogens Ann. Rev. Immunol. 21 2003 29 70
50. Z.Q. Zhang, S.W. Wietgrefe, Q. Li, M.D. Shore, L. Duan, C. Reilly, J.D. Lifson, and A.T. Haase Roles of substrate activity and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection Proc. Natl. Acad. Sci. USA 101 2004 5640 5645